Multiple Clinical Trials Now Recruiting for Type 1 Diabetes Research

Several research sites across the Pacific Northwest and beyond are actively recruiting participants for Type 1 diabetes clinical trials. These studies are testing investigational medicines designed to preserve or restore insulin production—a key goal in Type 1 diabetes research.

One trial is evaluating rezpegaldesleukin ("rezpeg"), an investigational medicine given as an injection every two weeks for six months. After the treatment period ends, participants enter a six-month monitoring phase. Researchers are studying whether this approach can preserve insulin secretion after a Type 1 diabetes diagnosis.

Another trial is examining CNP-103, described as a first-in-class, antigen-specific therapy. This investigational treatment is designed to preserve insulin production by targeting the autoimmune process that attacks beta cells—the cells that produce insulin. Researchers believe this approach may improve blood sugar control and long-term health outcomes.

Additional trials are also recruiting, including studies examining teplizumab and other experimental approaches.

Clinical trials recruit participants based on specific eligibility criteria, which vary by study. Some trials may be appropriate for people recently diagnosed with Type 1 diabetes, while others may focus on different groups.

If you're interested in learning more about whether a particular trial might be right for you, the Greater Northwest Chapter has trained Clinical Trial Education Volunteers (CTEV) available to answer questions and help guide your decision. These volunteers can explain what's involved in each study and help you understand your options.

For questions about clinical trials that might be appropriate for you, you can contact the Greater Northwest Chapter's Clinical Trial Education Volunteers by email or reach out to the main coordinator line at 1-800-888-4187.

The Greater Northwest Chapter also holds a quarterly update—the Pacific Northwest Research & Clinical Trials Quarterly Update—where they discuss specific trials and recent Type 1 diabetes research breakthroughs. These sessions provide an opportunity to learn more about the latest studies and where the field is headed.

Whether you're newly diagnosed, well-established in your Type 1 diabetes management, or supporting a loved one, learning about clinical trial opportunities can help you stay informed about emerging treatment options while contributing to the research that may help future patients.

Origin: Greater Northwest Chapter (News report). Evidence: News report, corroborated with 2 indexed studies. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.